What is a stock summary page? Click here for an overview.
Business Description
Genix Pharmaceuticals Corp
NAICS : 325412
SIC : 3741
ISIN : CA0209261019
Description
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically, the company operates only in Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -23.04 | |||||
| Debt-to-Equity | -0.7 | |||||
| Debt-to-EBITDA | 53.41 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -333.5 | |||||
| Beneish M-Score | -13.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 45 | |||||
| 3-Year FCF Growth Rate | 24.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 2.13 | |||||
| 9-Day RSI | 13.23 | |||||
| 14-Day RSI | 23.73 | |||||
| 3-1 Month Momentum % | -33.33 | |||||
| 6-1 Month Momentum % | -20 | |||||
| 12-1 Month Momentum % | -33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.04 | |||||
| Quick Ratio | 0.04 | |||||
| Days Inventory | 29200 | |||||
| Days Sales Outstanding | 456.25 | |||||
| Days Payable | 41902 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -12.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50 | |||||
| Operating Margin % | -6150 | |||||
| Net Margin % | -3025 | |||||
| FCF Margin % | -5175 | |||||
| ROA % | -72.98 | |||||
| ROIC % | -20.64 | |||||
| 3-Year ROIIC % | -33.55 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 35 | |||||
| EV-to-EBIT | 198.54 | |||||
| EV-to-EBITDA | 175.18 | |||||
| EV-to-Revenue | 744.5 | |||||
| EV-to-FCF | -15.82 | |||||
| Earnings Yield (Greenblatt) % | 0.51 | |||||
| FCF Yield % | -9.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genix Pharmaceuticals Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.004 | ||
| EPS (TTM) (C$) | 0.001 | ||
| Beta | 0.78 | ||
| 3-Year Sharpe Ratio | 0.02 | ||
| 3-Year Sortino Ratio | 0.04 | ||
| Volatility % | 95.04 | ||
| 14-Day RSI | 23.73 | ||
| 14-Day ATR (C$) | 0.001168 | ||
| 20-Day SMA (C$) | 0.041 | ||
| 12-1 Month Momentum % | -33.33 | ||
| 52-Week Range (C$) | 0.025 - 0.09 | ||
| Shares Outstanding (Mil) | 59.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genix Pharmaceuticals Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genix Pharmaceuticals Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genix Pharmaceuticals Corp Frequently Asked Questions
What is Genix Pharmaceuticals Corp(TSXV:GENX)'s stock price today?
The current price of TSXV:GENX is C$0.04. The 52 week high of TSXV:GENX is C$0.09 and 52 week low is C$0.03.
When is next earnings date of Genix Pharmaceuticals Corp(TSXV:GENX)?
The next earnings date of Genix Pharmaceuticals Corp(TSXV:GENX) is .
Does Genix Pharmaceuticals Corp(TSXV:GENX) pay dividends? If so, how much?
Genix Pharmaceuticals Corp(TSXV:GENX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers